John Bamforth
Net worth: - $ as of 2026-06-29
Net worth: - $ as of 2026-06-29
John P.
Bamforth is the founder of Ciara Arts & Science Foundation.
Current jobs include Chairman at Akanocure Pharmaceuticals LLC, Director at Rapidly Emerging Antiviral Drug Development Initiative, Independent Director at Humacyte, Inc. since 2024, and Executive Director at Eshelman Innovation since 2019.
Former jobs include Director at Structural Genomic Consortium from 2019 to 2021 and Chief Marketing Officer at Eli Lilly & Co. from 2012 to 2018.
Education includes an undergraduate degree from the University of Bath and a doctorate from the University of Aston.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
HUMACYTE, INC. -.--% | 2026-06-10 | 0 ( -.--% ) | - $ | 2026-06-29 |
| Companies | Position | Start |
|---|---|---|
| HUMACYTE, INC. | Director/Board Member | 2024-06-10 |
Akanocure Pharmaceuticals LLC
Akanocure Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Operates as a drug development company with a focus on oncology | Chairman | - |
Rapidly Emerging Antiviral Drug Development Initiative | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
| ELI LILLY AND COMPANY | Sales & Marketing | 2017-12-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
University of Bath
University of Bath Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Aston
University of Aston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akanocure Pharmaceuticals LLC
Akanocure Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Operates as a drug development company with a focus on oncology | Commercial Services |
Humacyte, Inc.
Humacyte, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Rapidly Emerging Antiviral Drug Development Initiative |
Select your edition
All financial news and data tailored to specific country editions